learn Metformin
diabetes drug with anti-inflammatory, immunomodulatory, and insulin-sensitizing properties
Search
forLearn
1 / 1 resultsResearch
5 / 1000+ resultsresearch Cicatricial Pemphigoid Rarely Involves the Scalp
Cicatricial pemphigoid rarely affects the scalp but is hard to treat when it does.
research Hair Loss in Autoimmune Cutaneous Bullous Disorders
Hair loss in autoimmune blistering skin diseases varies and may regrow with disease control.
research Diseases of Genital Skin in the Elderly
Older people often have untreated genital skin diseases due to embarrassment and lack of medical attention, which can lead to discomfort and even cancer risk.
research Histopathology of the Alopecias
Examining scalp tissue under a microscope helps diagnose and understand hair loss diseases.
research Scarring Alopecia in a 66-Year-Old Woman
A rare autoimmune disease caused the woman's scalp blisters and hair loss, successfully treated with medication.
Community Join
5 / 24 resultscommunity You will lose hair if your prostaglandins aren't in balance
Prostaglandin balance affects hair loss, particularly in conditions like Lichen Planopilaris, where an imbalance can lead to hair follicle damage. Treatments mentioned include prostaglandin analogs and Pioglitazone HCL, with a focus on maintaining prostaglandin equilibrium for potential hair regrowth.
community Concerned About Asymmetrical Frontal Hair Loss and Recent Finasteride Use, Seeking Experiences
The user is experiencing asymmetrical hair loss at the frontal hairline and is concerned about potential conditions like frontal fibrosing alopecia. They have started using finasteride and pumpkin seed oil to address the issue.
community Will PP405 need to be used indefinitely, like minoxidil?
PP405 may not need daily use like minoxidil, but finasteride might still be needed to maintain hair regrowth. PP405 reawakens dormant hair follicles, potentially offering a long-term solution, though not a permanent cure.
community Can we get a reality check on PP405?
PP405 is a promising hair loss treatment that may outperform minoxidil and finasteride by reviving dormant follicles and promoting significant regrowth. Results from ongoing trials are awaited, with a potential market release between 2028-2030.
community Pelage, PP405, is creating a database for potential new trial volunteers
PP405 is a new hair loss treatment targeting dormant hair follicles, with ongoing trials. Some users consider stopping finasteride and minoxidil to join trials, while others doubt its effectiveness.